1.
ChiCTR; 2024-02-18; TrialID: ChiCTR2400080915
Clinical Trial Register
| ICTRP | ID: ictrp-ChiCTR2400080915
ABSTRACT
Condition:
Long covidIntervention:
Observation Group:None;Primary outcome:
Incidence;Fatigue Severity Scale;Criteria:
Inclusion criteria: This prospective cohort study encompasses a diverse patient population, ranging from neonates to individuals above 90, diagnosed with COVID-19. Patients admitted to the Gansu Provincial Hospital, Lanzhou, China, from December 2022 to May 2023, with RT-PCR confirmed SARS-CoV-2 infection, form the study cohort.Exclusion criteria: Exclusions include patients with incomplete contact details, deceased during hospitalization or follow-up, those declining participation, or unreachable for follow-up.